Delivery Order SPE2DX15D2921-SPE2DX21FSEDN
Award Date 9/17/21
Potential Completion Date 9/20/21
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 1,440 units of HAVRIX vaccine in 1 ml syringes. The potential value of this firm fixed price contract is $2,033.40. Performance will occur in Park Ridge, Illinois, with delivery required no later than January 25, 2023. No set-aside provisions were applied to this award in support of the Defense Logistics Agency's medical supply chain responsibilities.</p>
- This is a $9,088.35 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The award has an ultimate completion date of April 9, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product, with a ceiling value of $1,049.30. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation for the supply of HAVRIX 1,440 unit/mL syringes. The delivery order, valued at $2,435.05, is a firm fixed-price contract with a completion date of September 16, 2024. This award appears to be part of a larger indefinite delivery contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- The Defense Logistics Agency awarded a delivery order valued at $1,520.49 to AmerisourceBergen Drug Corp for 1,440 units of HAVRIX 1,440 Unit/mL syringe, a hepatitis A vaccine. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating the award was made through open competition among qualified vendors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix 1 unit/mL syringes valued at $14,927.65 on May 27, 2025, with a completion date of May 28, 2025. This is a firm fixed-price, non-set-aside contract with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Havrix is a hepatitis A vaccine commonly used in military and federal healthcare settings to maintain disease prevention across the armed forces and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,827.27 contract is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a vaccine product. The award has a completion date of May 20, 2025 and is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,440 units of HAVRIX 1,440 Unit/mL syringe on August 26, 2025, with a ceiling value of $2,017.25 and an ultimate completion date of August 27, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract represents a single transaction for the hepatitis A vaccine product, which will be performed at AmerisourceBergen's corporate...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $3,468.60 to supply 4563044651 HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility, with completion by December 11, 2023. No set aside designation was applied to this order, which was awarded against an indefinite delivery contract held by Amerisourcebergen with the Department of Justice FBI...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,905.50 contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 22, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is the prime contractor. Amerisourcebergen holds...
- SPE2DX15D2921Indefinite Delivery Contract
- SPE2DX15D2921-SPE2DX21FSEDNDelivery Order
4554933433 ! HAVRIX 1,440 UNITS/ML SYRINGEML
Posted 9/17/21
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.5k | 9/17/21 |